Buy Wegovy Weight Loss Pen.

Wegovy Weight Loss Pen

Wegovy is a prescription weight loss treatment taken weekly, containing the active ingredient semaglutide, a GLP-1 analogue. It can be prescribed for overweight adults with a BMI of 27 kg/m2 or higher or those experiencing medical issues related to their weight, such as type 2 diabetes, high blood pressure, or high cholesterol. Wegovy is available in 5 doses ranging from 0.25 mg to 2.4 mg, each of which is taken once a week. Each dose comes in a different color pen

How do I use a Wegovy Weight Loss Pen .

The Wegovy Pen is a disposable one-time use pen that is prescribed for weight loss. It is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm using a pen device1.

Here are some steps on how to use the Wegovy Pen:

Check the label on the pen to make sure it is the correct medicine and dose.

Wash your hands with soap and water.

Choose an injection site on your stomach (abdomen), thigh, or upper arm.

Clean the injection site with an alcohol swab and let it dry.

Remove the cap from the pen.

Pinch a fold of skin at the injection site.

Insert the needle into your skin at a 90-degree angle.

Press and hold down the dose button until you hear a click.

Remove the needle from your skin and release the dose button.

Place a cotton ball or gauze over the injection site and press down for several seconds2.

I hope this helps! Let me know if you have any other questions.

How much weight has Wegovy Weight Loss Pen lost compared to a placebo?                                                  Wegovy is a weight loss drug. Patients taking Wegovy lost an average of 35 lbs (15.9 kg), or about 15% of their body weight compared to 6 lbs (2.7 kg), or roughly 2.5% body weight in the placebo group1. After 68 weeks, 83% of adults taking Wegovy lost 5% or more of their weight compared to 31% of adults taking a placebo12. In a test of Wegovy in adults without diabetes, those who received Wegovy lost an average of 12.4% of their initial body weight compared to those who received a placebo3. In the STEP 5 trial, results showed that Wegovy significantly reduced body weight from baseline to week 104 compared to placebo (-15.2% vs. -2.6%)4.